2026 ASCO Breast Cancer Highlights: HER2CLIMB-05 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

2026 ASCO Breast Cancer Highlights: HER2CLIMB-05

Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the HER2Climb-05 trial and how it impacts treatment for HER2+ metastatic breast cancer

  • October 15, 2026

Share

Objective:

Harold Burstein, MD, PhD, and Adrienne Waks, MD, discuss the HER2CLIMB-05 trial and its relevance to treatment for HER2-positive metastatic breast cancer.

Limitations:
  • Only the title and a brief description of the video were provided; no transcript or trial details were available.

Original Source(s)

2026 ASCO Breast Cancer Highlights: HER2CLIMB-05

  • October 15, 2026

Related Content

EQUIPOISE: EQUivalence In Prostate cancer treatment: surgery Or radiotherapy? An Intention-to-treat Survival analysis from real-world Evidence

2026 ASCO Breast Cancer Highlights: Food Access, Poverty, and MBC

Harold Burstein, MD, PhD, and Rachel Freedman, MD, MPH discuss the results of a new study looking at the impact of food access and poverty on patients with metastatic breast cancer. They also discuss the new Dana-Farber food pantry and patient navigators who help coordinate care.

  • October 15, 2026

  • 1 min
Topical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?